Overall rank by patents
#26,099
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Deutsches Rheuma-forschungszentrum Berlin
USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
10
Total patents granted
11
CPC technology areas
15.6
Avg claims per patent
+50%
5-year filing velocity
The verdict
Deutsches holds 10 US patents across 11 technology areas, rank #26,099 of 50,000 tracked assignees.
- #26,099
- of 50,000 US assignees by volume
- Top 48%
- by Innovation Score (36.0/100)
- 15.6
- avg claims per patent
- +50%
- filing velocity, last 5 yrs
Portfolio overview
Deutsches Rheuma-forschungszentrum Berlin has been granted 10 US utility patents between 2016 and 2025, placing Deutsches Rheuma-forschungszentrum Berlin at rank #26,099 across all assignees tracked by PlainPatent. This portfolio spans 11 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.6 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a Foreign Corporation, Deutsches Rheuma-forschungszentrum Berlin is one of the more focused assignees in the PatentsView dataset. By volume, Deutsches sits between DB Equipment AS (10 patents, rank #26,095) and Diasorin S.p.a. (10 patents, rank #26,103) - the closest US assignees by grant volume. The composite Innovation Score of 36.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 4 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Deutsches Rheuma-forschungszentrum Berlin's 15.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 11 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Deutsches Rheuma-forschungszentrum Berlin against peers pursuing similar technology classes.
Who files at Deutsches's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- DB Equipment AS
DB Equipment AS
10 patents
- DB Innovation
DB INNOVATION INC.
10 patents
- DE Greef's Wagen-…
DE GREEF'S WAGEN-, CARROSSERIE-EN MACHINEBOUW B.V
10 patents
- Delta Energy & Co…
DELTA ENERGY & COMMUNICATIONS, INC.
10 patents
- Devar Entertainme…
DEVAR ENTERTAINMENT LIMITED
10 patents
- Devon Energy
DEVON ENERGY CORPORATION
10 patents
- Diagnostica Stago
DIAGNOSTICA STAGO
10 patents
- Diasorin S p A
DIASORIN S.p.A.
10 patents
- Deutsches Rheuma-… ◀
DEUTSCHES RHEUMA-FORSCHUNGSZENTRUM BERLIN
10 patents
What this shows Deutsches holds 10 patents at rank #26,099, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Deutsches's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 48% higher than 52% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 10.0% |
| 2017 | 1 | 10.0% |
| 2018 | 1 | 10.0% |
| 2019 | 1 | 10.0% |
| 2020 | 1 | 10.0% |
| 2021 | 1 | 10.0% |
| 2022 | 2 | 20.0% |
| 2023 | 1 | 10.0% |
| 2025 | 1 | 10.0% |
Which technologies does Deutsches Rheuma-forschungszentrum Berlin patent most?
Top 11 of 11 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does Deutsches Rheuma-forschungszentrum Berlin hold?
Deutsches Rheuma-forschungszentrum Berlin holds 10 US granted patents filed between 2016 and 2025, spanning 11 technology areas.
What is Deutsches Rheuma-forschungszentrum Berlin's Innovation Score?
Deutsches Rheuma-forschungszentrum Berlin has an Innovation Score of 36.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Deutsches Rheuma-forschungszentrum Berlin focus on?
Deutsches Rheuma-forschungszentrum Berlin's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 6 patents. The company has filed patents in 11 CPC subclasses total.
Is Deutsches Rheuma-forschungszentrum Berlin's patent filing rate increasing or decreasing?
Deutsches Rheuma-forschungszentrum Berlin's recent filing velocity is +50% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Deutsches Rheuma-forschungszentrum Berlin's patents?
Deutsches Rheuma-forschungszentrum Berlin's patents average 15.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Deutsches Rheuma-forschungszentrum Berlin patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Deutsches's 10 grants land it in the top 48% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Deutsches ranks #26,099 of 50,000. Top 50 holders
- Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.